• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米信息学与个性化医学:癌症管理的高级累积方法。

Nanoinformatics and Personalized Medicine: An Advanced Cumulative Approach for Cancer Management.

机构信息

Department of Bioengineering, Faculty of Engineering, Integral University, Lucknow - 226026, UP, India.

Novel Global Community Educational Foundation, Hebersham, NSW2770, Australia.

出版信息

Curr Med Chem. 2023;30(3):271-285. doi: 10.2174/0929867329666220610090405.

DOI:10.2174/0929867329666220610090405
PMID:35692148
Abstract

BACKGROUND

Even though the battle against one of the deadliest diseases, cancer, has advanced remarkably in the last few decades and the survival rate has improved significantly; the search for an ultimate cure remains a utopia. Nanoinformatics, which is bioinformatics coupled with nanotechnology, endows many novel research opportunities in the preclinical and clinical development of personalized nanosized drug carriers in cancer therapy. Personalized nanomedicines serve as a promising treatment option for cancer owing to their noninvasiveness and their novel approach. Explicitly, the field of personalized medicine is expected to have an enormous impact soon because of its many advantages, namely its versatility to adapt a drug to a cohort of patients.

OBJECTIVE

The current review explains the application of this newly emerging field called nanoinformatics to the field of precision medicine. This review also recapitulates how nanoinformatics could hasten the development of personalized nanomedicine for cancer, which is undoubtedly the need of the hour.

CONCLUSION

This approach has been facilitated by a humongous impending field named Nanoinformatics. These breakthroughs and advances have provided insight into the future of personalized medicine. Imperatively, they have been enabling landmark research to merge all advances, creating nanosized particles that contain drugs targeting cell surface receptors and other potent molecules designed to kill cancerous cells. Nanoparticle- based medicine has been developing and has become a center of attention in recent years, focusing primely on proficient delivery systems for various chemotherapy drugs.

摘要

背景

尽管在过去几十年中,人类在对抗最致命的疾病之一——癌症方面取得了显著进展,生存率也有了显著提高,但寻找终极治愈方法仍然是一种乌托邦式的幻想。纳米信息学是生物信息学与纳米技术的结合,为癌症治疗中个性化纳米药物载体的临床前和临床开发带来了许多新的研究机会。个性化纳米药物由于其非侵入性和新颖的治疗方法,有望成为癌症治疗的一种有前途的治疗选择。具体来说,由于其多功能性,即能够根据患者群体调整药物,个性化医学领域有望很快产生巨大影响。

目的

本综述解释了这个新兴领域纳米信息学在精准医学领域的应用。本文还回顾了纳米信息学如何加速癌症个性化纳米医学的发展,这无疑是当前的迫切需求。

结论

这种方法得益于一个名为纳米信息学的庞大新兴领域。这些突破和进展为个性化医学的未来提供了新的思路。至关重要的是,它们使得各种先进技术能够融合,创造出载有针对细胞表面受体和其他强效分子的药物的纳米颗粒,这些分子旨在杀死癌细胞。基于纳米粒子的药物在近年来得到了发展,并成为关注的焦点,主要集中在各种化疗药物的高效传递系统上。

相似文献

1
Nanoinformatics and Personalized Medicine: An Advanced Cumulative Approach for Cancer Management.纳米信息学与个性化医学:癌症管理的高级累积方法。
Curr Med Chem. 2023;30(3):271-285. doi: 10.2174/0929867329666220610090405.
2
Nanoinformatics and DNA-based computing: catalyzing nanomedicine.纳米信息学和基于 DNA 的计算:促进纳米医学。
Pediatr Res. 2010 May;67(5):481-9. doi: 10.1203/PDR.0b013e3181d6245e.
3
Nanoinformatics and biomolecular nanomodeling: a novel move en route for effective cancer treatment.纳米信息学和生物分子纳米建模:有效癌症治疗的新途径。
Environ Sci Pollut Res Int. 2020 Jun;27(16):19127-19141. doi: 10.1007/s11356-019-05152-8. Epub 2019 Apr 25.
4
Nanoinformatics Revolutionizes Personalized Cancer Therapy.纳米信息学彻底改变个性化癌症治疗。
Trends Cancer. 2018 Jun;4(6):397-399. doi: 10.1016/j.trecan.2018.04.002. Epub 2018 Apr 25.
5
International efforts in nanoinformatics research applied to nanomedicine.应用于纳米医学的纳米信息学研究的国际努力。
Methods Inf Med. 2011;50(1):84-95. doi: 10.3414/ME10-02-0012. Epub 2010 Nov 18.
6
Nanomedicine-based neuroprotective strategies in patient specific-iPSC and personalized medicine.基于纳米医学的针对患者特异性诱导多能干细胞及个性化医疗的神经保护策略。
Int J Mol Sci. 2014 Mar 4;15(3):3904-25. doi: 10.3390/ijms15033904.
7
Personalized Nanomedicine: A Revolution at the Nanoscale.个性化纳米医学:纳米尺度的一场革命。
J Pers Med. 2017 Oct 12;7(4):12. doi: 10.3390/jpm7040012.
8
Advanced nanomedicine and cancer: Challenges and opportunities in clinical translation.先进的纳米医学与癌症:临床转化中的挑战与机遇。
Int J Pharm. 2021 Apr 15;599:120438. doi: 10.1016/j.ijpharm.2021.120438. Epub 2021 Mar 2.
9
Nanoinformatics: new challenges for biomedical informatics at the nano level.纳米信息学:纳米层面生物医学信息学面临的新挑战。
Stud Health Technol Inform. 2009;150:987-91.
10
Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.癌症治疗的靶向纳米医学:迈向克服耐药性的精准医学。
Drug Resist Updat. 2017 Mar;31:15-30. doi: 10.1016/j.drup.2017.05.002. Epub 2017 May 21.

引用本文的文献

1
The Role of Proteomics and Genomics in the Development of Colorectal Cancer Diagnostic Tools and Potential New Treatments.蛋白质组学和基因组学在结直肠癌诊断工具开发及潜在新疗法中的作用
ACS Pharmacol Transl Sci. 2025 Apr 10;8(5):1227-1250. doi: 10.1021/acsptsci.4c00686. eCollection 2025 May 9.
2
New Theobromine Apoptotic Analogue with Anticancer Potential Targeting the EGFR Protein: Computational and Studies.靶向表皮生长因子受体(EGFR)蛋白的具有抗癌潜力的新型可可碱凋亡类似物:计算与实验研究
ACS Omega. 2024 Mar 27;9(14):15861-15881. doi: 10.1021/acsomega.3c08148. eCollection 2024 Apr 9.
3
Current Intellectual Glance Over Nanoparticles in Cancer and Neurodegenerative Research.

本文引用的文献

1
Evolution of macromolecular complexity in drug delivery systems.药物递送系统中大分子复杂性的演变。
Nat Rev Chem. 2017 Aug;1(8). doi: 10.1038/s41570-017-0063. Epub 2017 Aug 9.
2
Personalized medicine in non-small cell lung cancer: a review from a pharmacogenomics perspective.非小细胞肺癌中的个性化医疗:从药物基因组学角度的综述
Acta Pharm Sin B. 2018 Jul;8(4):530-538. doi: 10.1016/j.apsb.2018.04.005. Epub 2018 Apr 30.
3
Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers.779 例高级别分化型和间变性甲状腺癌的遗传学分析。
当前关于纳米颗粒在癌症与神经退行性疾病研究中的学术综述
Curr Med Chem. 2023;30(3):251-254. doi: 10.2174/092986733003221121163821.
Clin Cancer Res. 2018 Jul 1;24(13):3059-3068. doi: 10.1158/1078-0432.CCR-18-0373. Epub 2018 Apr 3.
4
Application of computational methods for anticancer drug discovery, design, and optimization.计算方法在抗癌药物发现、设计和优化中的应用。
Bol Med Hosp Infant Mex. 2016 Nov-Dec;73(6):411-423. doi: 10.1016/j.bmhimx.2016.10.006. Epub 2016 Nov 30.
5
Quantitative self-assembly prediction yields targeted nanomedicines.定量自组装预测可得到靶向纳米药物。
Nat Mater. 2018 Apr;17(4):361-368. doi: 10.1038/s41563-017-0007-z. Epub 2018 Feb 5.
6
Predicting Nano-Bio Interactions by Integrating Nanoparticle Libraries and Quantitative Nanostructure Activity Relationship Modeling.通过整合纳米粒子库和定量纳米结构活性关系模型来预测纳米生物相互作用。
ACS Nano. 2017 Dec 26;11(12):12641-12649. doi: 10.1021/acsnano.7b07093. Epub 2017 Nov 22.
7
Personalized Nanomedicine: A Revolution at the Nanoscale.个性化纳米医学:纳米尺度的一场革命。
J Pers Med. 2017 Oct 12;7(4):12. doi: 10.3390/jpm7040012.
8
Clinical impact of recurrently mutated genes on lymphoma diagnostics: state-of-the-art and beyond.复发性突变基因对淋巴瘤诊断的临床影响:现状与展望
Haematologica. 2016 Sep;101(9):1002-9. doi: 10.3324/haematol.2015.134510.
9
A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics.一种经过验证的结直肠癌代谢组学特征:代谢组学临床价值探索
Br J Cancer. 2016 Sep 27;115(7):848-57. doi: 10.1038/bjc.2016.243. Epub 2016 Aug 25.
10
Cancer in silico drug discovery: a systems biology tool for identifying candidate drugs to target specific molecular tumor subtypes.癌症的计算机辅助药物发现:一种用于识别针对特定分子肿瘤亚型的候选药物的系统生物学工具。
Mol Cancer Ther. 2014 Dec;13(12):3230-40. doi: 10.1158/1535-7163.MCT-14-0260. Epub 2014 Oct 27.